Nemaura Medical: Rises on plans to launch patch to monitor fever

Nemaura Medical

01/04/2020 15:22

** Shares of medical device maker  NMRD.O  rise 13.5% to
$6.65 - top pct gainer across U.S. exchanges
    ** Co plans to launch Body-Worn Continuous Temperature
Monitor to track fevers due to viral infections such as COVID-19
 urn:newsml:reuters.com:*:nBw35HyxSa
    ** Will repurpose sugarBEAT, co's continuous glucose
monitoring system, which has an inbuilt temperature sensor, co
said
    ** The device is CE approved in Europe and in commercial
production in the UK
    ** Continuous Temperature Monitors have been recognised as
potentially having a key role to play in battling COVID-19, co
says
    ** Stock almost doubled in value YTD as of last close

 (Reporting by Trisha Roy in Bengaluru)
 ((Trisha.Roy@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3635;))